Curesign
PrivateLast Round
Seed
Feb 1, 2020
Company Overview
Curesign is a therapeutic devices company that develops medical devices designed to optimize oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Medical AI, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curesign Comparables
Compare Curesign with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 66% | |
| Adiposs | 59% | |
| VieCure | 57% |
Curesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2020 |
Curesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peregrine Ventures | Seed |
| Nacre Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2020
Raised capital from Nacre Capital and Peregrine Ventures.
Curesign Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curesign's valuation, stock price, and market status.
Is Curesign a public or private company?
Curesign is a private company.
What is the current stock price of Curesign?
Curesign is a private company with no public stock price. No recent secondary market data is available.
How much is Curesign worth (valuation)?
Valuation information for Curesign is not publicly available.
Can I buy Curesign stock?
Curesign shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curesign's last funding round?
Funding round information for Curesign is not publicly available.
Who are the main investors in Curesign?
Investor information for Curesign is not publicly disclosed.
Will Curesign IPO soon?
No public IPO plans have been announced for Curesign.
How can I track Curesign secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curesign's secondary market activity and sign up for updates.